Genetic variants in the MRPS30 region and postmenopausal breast cancer risk

Ying Huang, Dennis G. Ballinger, James Y. Dai, Ulrike Peters, David A. Hinds, David R. Cox, Erica Beilharz, Rowan T. Chlebowski, Jacques E. Rossouw, Anne McTiernan, Thomas E. Rohan, Ross L. Prentice

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Genome-wide association studies have identified several genomic regions that are associated with breast cancer risk, but these provide an explanation for only a small fraction of familial breast cancer aggregation. Genotype by environment interactions may contribute further to such explanation, and may help to refine the genomic regions of interest.Methods: We examined genotypes for 4,988 SNPs, selected from recent genome-wide studies, and four randomized hormonal and dietary interventions among 2,166 women who developed invasive breast cancer during the intervention phase of the Women's Health Initiative (WHI) clinical trial (1993 to 2005), and one-to-one matched controls. These SNPs derive from 3,224 genomic regions having pairwise squared correlation (r2) between adjacent regions less than 0.2. Breast cancer and SNP associations were identified using a test statistic that combined evidence of overall association with evidence for SNPs by intervention interaction.Results: The combined 'main effect' and interaction test led to a focus on two genomic regions, the fibroblast growth factor receptor two (FGFR2) and the mitochondrial ribosomal protein S30 (MRPS30) regions. The ranking of SNPs by significance level, based on this combined test, was rather different from that based on the main effect alone, and drew attention to the vicinities of rs3750817 in FGFR2 and rs7705343 in MRPS30. Specifically, rs7705343 was included with several FGFR2 SNPs in a group of SNPs having an estimated false discovery rate < 0.05. In further analyses, there were suggestions (nominal P < 0.05) that hormonal and dietary intervention hazard ratios varied with the number of minor alleles of rs7705343.Conclusions: Genotype by environment interaction information may help to define genomic regions relevant to disease risk. Combined main effect and intervention interaction analyses raise novel hypotheses concerning the MRPS30 genomic region and the effects of hormonal and dietary exposures on postmenopausal breast cancer risk.

Original languageEnglish (US)
Article number42
JournalGenome Medicine
Volume3
Issue number6
DOIs
StatePublished - Jun 24 2011

Fingerprint

Mitochondrial Proteins
Single Nucleotide Polymorphism
Breast Neoplasms
Genotype
Fibroblast Growth Factor Receptors
Genome-Wide Association Study
Women's Health
ribosomal protein S30
Alleles
Clinical Trials
Genome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Molecular Biology
  • Molecular Medicine

Cite this

Huang, Y., Ballinger, D. G., Dai, J. Y., Peters, U., Hinds, D. A., Cox, D. R., ... Prentice, R. L. (2011). Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Medicine, 3(6), [42]. https://doi.org/10.1186/gm258

Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. / Huang, Ying; Ballinger, Dennis G.; Dai, James Y.; Peters, Ulrike; Hinds, David A.; Cox, David R.; Beilharz, Erica; Chlebowski, Rowan T.; Rossouw, Jacques E.; McTiernan, Anne; Rohan, Thomas E.; Prentice, Ross L.

In: Genome Medicine, Vol. 3, No. 6, 42, 24.06.2011.

Research output: Contribution to journalArticle

Huang, Y, Ballinger, DG, Dai, JY, Peters, U, Hinds, DA, Cox, DR, Beilharz, E, Chlebowski, RT, Rossouw, JE, McTiernan, A, Rohan, TE & Prentice, RL 2011, 'Genetic variants in the MRPS30 region and postmenopausal breast cancer risk', Genome Medicine, vol. 3, no. 6, 42. https://doi.org/10.1186/gm258
Huang Y, Ballinger DG, Dai JY, Peters U, Hinds DA, Cox DR et al. Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Medicine. 2011 Jun 24;3(6). 42. https://doi.org/10.1186/gm258
Huang, Ying ; Ballinger, Dennis G. ; Dai, James Y. ; Peters, Ulrike ; Hinds, David A. ; Cox, David R. ; Beilharz, Erica ; Chlebowski, Rowan T. ; Rossouw, Jacques E. ; McTiernan, Anne ; Rohan, Thomas E. ; Prentice, Ross L. / Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. In: Genome Medicine. 2011 ; Vol. 3, No. 6.
@article{0170826964d64ee48c1660db283a4a05,
title = "Genetic variants in the MRPS30 region and postmenopausal breast cancer risk",
abstract = "Background: Genome-wide association studies have identified several genomic regions that are associated with breast cancer risk, but these provide an explanation for only a small fraction of familial breast cancer aggregation. Genotype by environment interactions may contribute further to such explanation, and may help to refine the genomic regions of interest.Methods: We examined genotypes for 4,988 SNPs, selected from recent genome-wide studies, and four randomized hormonal and dietary interventions among 2,166 women who developed invasive breast cancer during the intervention phase of the Women's Health Initiative (WHI) clinical trial (1993 to 2005), and one-to-one matched controls. These SNPs derive from 3,224 genomic regions having pairwise squared correlation (r2) between adjacent regions less than 0.2. Breast cancer and SNP associations were identified using a test statistic that combined evidence of overall association with evidence for SNPs by intervention interaction.Results: The combined 'main effect' and interaction test led to a focus on two genomic regions, the fibroblast growth factor receptor two (FGFR2) and the mitochondrial ribosomal protein S30 (MRPS30) regions. The ranking of SNPs by significance level, based on this combined test, was rather different from that based on the main effect alone, and drew attention to the vicinities of rs3750817 in FGFR2 and rs7705343 in MRPS30. Specifically, rs7705343 was included with several FGFR2 SNPs in a group of SNPs having an estimated false discovery rate < 0.05. In further analyses, there were suggestions (nominal P < 0.05) that hormonal and dietary intervention hazard ratios varied with the number of minor alleles of rs7705343.Conclusions: Genotype by environment interaction information may help to define genomic regions relevant to disease risk. Combined main effect and intervention interaction analyses raise novel hypotheses concerning the MRPS30 genomic region and the effects of hormonal and dietary exposures on postmenopausal breast cancer risk.",
author = "Ying Huang and Ballinger, {Dennis G.} and Dai, {James Y.} and Ulrike Peters and Hinds, {David A.} and Cox, {David R.} and Erica Beilharz and Chlebowski, {Rowan T.} and Rossouw, {Jacques E.} and Anne McTiernan and Rohan, {Thomas E.} and Prentice, {Ross L.}",
year = "2011",
month = "6",
day = "24",
doi = "10.1186/gm258",
language = "English (US)",
volume = "3",
journal = "Genome Medicine",
issn = "1756-994X",
publisher = "BioMed Central",
number = "6",

}

TY - JOUR

T1 - Genetic variants in the MRPS30 region and postmenopausal breast cancer risk

AU - Huang, Ying

AU - Ballinger, Dennis G.

AU - Dai, James Y.

AU - Peters, Ulrike

AU - Hinds, David A.

AU - Cox, David R.

AU - Beilharz, Erica

AU - Chlebowski, Rowan T.

AU - Rossouw, Jacques E.

AU - McTiernan, Anne

AU - Rohan, Thomas E.

AU - Prentice, Ross L.

PY - 2011/6/24

Y1 - 2011/6/24

N2 - Background: Genome-wide association studies have identified several genomic regions that are associated with breast cancer risk, but these provide an explanation for only a small fraction of familial breast cancer aggregation. Genotype by environment interactions may contribute further to such explanation, and may help to refine the genomic regions of interest.Methods: We examined genotypes for 4,988 SNPs, selected from recent genome-wide studies, and four randomized hormonal and dietary interventions among 2,166 women who developed invasive breast cancer during the intervention phase of the Women's Health Initiative (WHI) clinical trial (1993 to 2005), and one-to-one matched controls. These SNPs derive from 3,224 genomic regions having pairwise squared correlation (r2) between adjacent regions less than 0.2. Breast cancer and SNP associations were identified using a test statistic that combined evidence of overall association with evidence for SNPs by intervention interaction.Results: The combined 'main effect' and interaction test led to a focus on two genomic regions, the fibroblast growth factor receptor two (FGFR2) and the mitochondrial ribosomal protein S30 (MRPS30) regions. The ranking of SNPs by significance level, based on this combined test, was rather different from that based on the main effect alone, and drew attention to the vicinities of rs3750817 in FGFR2 and rs7705343 in MRPS30. Specifically, rs7705343 was included with several FGFR2 SNPs in a group of SNPs having an estimated false discovery rate < 0.05. In further analyses, there were suggestions (nominal P < 0.05) that hormonal and dietary intervention hazard ratios varied with the number of minor alleles of rs7705343.Conclusions: Genotype by environment interaction information may help to define genomic regions relevant to disease risk. Combined main effect and intervention interaction analyses raise novel hypotheses concerning the MRPS30 genomic region and the effects of hormonal and dietary exposures on postmenopausal breast cancer risk.

AB - Background: Genome-wide association studies have identified several genomic regions that are associated with breast cancer risk, but these provide an explanation for only a small fraction of familial breast cancer aggregation. Genotype by environment interactions may contribute further to such explanation, and may help to refine the genomic regions of interest.Methods: We examined genotypes for 4,988 SNPs, selected from recent genome-wide studies, and four randomized hormonal and dietary interventions among 2,166 women who developed invasive breast cancer during the intervention phase of the Women's Health Initiative (WHI) clinical trial (1993 to 2005), and one-to-one matched controls. These SNPs derive from 3,224 genomic regions having pairwise squared correlation (r2) between adjacent regions less than 0.2. Breast cancer and SNP associations were identified using a test statistic that combined evidence of overall association with evidence for SNPs by intervention interaction.Results: The combined 'main effect' and interaction test led to a focus on two genomic regions, the fibroblast growth factor receptor two (FGFR2) and the mitochondrial ribosomal protein S30 (MRPS30) regions. The ranking of SNPs by significance level, based on this combined test, was rather different from that based on the main effect alone, and drew attention to the vicinities of rs3750817 in FGFR2 and rs7705343 in MRPS30. Specifically, rs7705343 was included with several FGFR2 SNPs in a group of SNPs having an estimated false discovery rate < 0.05. In further analyses, there were suggestions (nominal P < 0.05) that hormonal and dietary intervention hazard ratios varied with the number of minor alleles of rs7705343.Conclusions: Genotype by environment interaction information may help to define genomic regions relevant to disease risk. Combined main effect and intervention interaction analyses raise novel hypotheses concerning the MRPS30 genomic region and the effects of hormonal and dietary exposures on postmenopausal breast cancer risk.

UR - http://www.scopus.com/inward/record.url?scp=79959473080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959473080&partnerID=8YFLogxK

U2 - 10.1186/gm258

DO - 10.1186/gm258

M3 - Article

VL - 3

JO - Genome Medicine

JF - Genome Medicine

SN - 1756-994X

IS - 6

M1 - 42

ER -